-+ 0.00%
-+ 0.00%
-+ 0.00%

BLACK DIAMOND: TO INITIATE RANDOMIZED PHASE 2 TRIAL OF SILEVERTINIB IN NEWLY DIAGNOSED GBM PATIENTS IN 1H 2026; INITIAL DATA ANTICIPATED IN 2028

Reuters·12/03/2025 12:01:00

Please log in to view news